ACE GENE POLYMORPHISM IN CHILDHOOD IGA NEPHROPATHY - ASSOCIATION WITHCLINICOPATHOLOGICAL FINDINGS
Citation
R. Tanaka et al., ACE GENE POLYMORPHISM IN CHILDHOOD IGA NEPHROPATHY - ASSOCIATION WITHCLINICOPATHOLOGICAL FINDINGS, American journal of kidney diseases, 31(5), 1998, pp. 774-779
Categorie Soggetti
Urology & Nephrology
SICI code
0272-6386(1998)31:5<774:AGPICI>2.0.ZU;2-H
Abstract
A deletion polymorphism in the angiotensin-converting enzyme (ACE) gen
e has been reported to be a risk factor for progression to chronic ren
al failure in immunoglobulin A nephropathy (IgAN). In this study, we I
nvestigated the association between ACE gene polymorphism and clinical
findings, early biopsy findings such as the extent of mesangial proli
feration, focal lesions (capsular adhesions, glomerulosclerosis, and c
rescents), and the glomerular area in childhood IgAN. Genomic DNA was
obtained from 97 patients and control subjects. Gene polymorphisms, co
nsisting of an insertion (I) or deletion (D) of the 287-base pair Alu
sequence, were detected using the polymerase chain reaction. The exten
t of capsular adhesions and glomerulosclerosis was significantly highe
r in patients with the ID/DD genotypes than in those with the II genot
ype (ID/DD v II: 8.0% +/- 1.4% v 2.5% +/- 0.8% [P = 0.017] and 5.1% +/
- 1.3% v 1.4% +/- 0.6% [P = 0.028], respectively). Whereas there was n
o difference in the extent of mesangial proliferation and crescents be
tween the ID/DD genotypes and the II genotype. Urinary protein excreti
on at the time of biopsy was significantly greater in patients with th
e ID/DD genotypes than in those with the II genotype (1.02 +/- 0.15 g/
d/m(2) body surface area v 0.56 +/- 0.13 g/d/m(2) body surface area; P
= 0.012). These results indicate that ACE gene polymorphism may not i
nfluence the extent of mesangial proliferation and crescents that are
acute lesions. However, the ID/DD genotypes are associated with chroni
c lesions, such as capsular adhesions or glomerulosclerosis and urinar
y protein excretion in childhood IgAN. (C) 1998 by the National Kidney
Foundation, Inc.